Background: Metabolic risk factors represent a major cause of increased coronary heart disease morbidity and mortality among psychosis patients. Although antipsychotic medication may lead to hyperglycemia, an association to severe mental illness was established before the introduction of antipsychotics.
Hukic, D. S., & Olsson, E. (2016). Genes Associated with Increased Fasting Glucose in Patients with Schizophrenia Spectrum Disorders. Journal of Diabetes & Metabolism, 6(3). https://doi.org/10.4172/2155-6156.1000512